Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

PLX Protalix BioTherapeutics Inc

2,33

-0,02 (-0,85%)

08 Mär 2025 - Geschlossen

Verzögert um 15 Minuten

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Protalix BioTherapeutics (AMEX:PLX)
Historical Stock Chart
Von Feb 2025 bis Mär 2025

Click Here for more Protalix BioTherapeutics Charts.

Protalix BioTherapeutics (AMEX:PLX)
Historical Stock Chart
Von Mär 2024 bis Mär 2025

Click Here for more Protalix BioTherapeutics Charts.

News Protalix BioTherapeutics Inc

Form 8-K - Current report
Dienstag 31 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 23 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 14 November 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 14 November 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Dienstag 5 November 2024 (4 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Freitag 25 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 25 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 24 September 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 24 September 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 14 August 2024 (7 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 14 August 2024 (7 Monate vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Freitag 17 Mai 2024 (10 Monate vor) • Edgar (US Regulatory)

Weitere Protalix BioTherapeutics Inc News-Artikel

Exchange Trading Funds

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen